Survey on chemotherapy side effects in Chinese cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This survey studies how chemotherapy lowers blood cell counts (myelosuppression) in people with certain cancers, such as lung, breast, stomach, or colon cancer. It aims to help doctors better manage this side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these cancers: non-small cell lung cancer, small cell lung cancer, breast cancer, stomach cancer, esophageal cancer, colorectal cancer, or a gynecological cancer (ovarian, cervical, or endometrial).
- You have received chemotherapy in the past 3 months and plan to continue it.
- You had at least 1 or 2 blood tests within a week after your last chemo session.
- Your most recent chemotherapy used one of the specific drug combinations listed for your cancer type.
- You do not have active bleeding and have not had recent radiation to your flat bones (like the sternum or pelvis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a study drug (Thiopegfilgrastim) can help prevent a dangerous drop in white blood cells (bone marrow suppression) in people with esophageal or lung cancer who are getting chemo and radiation. It may reduce your risk of infection during treatment.
This study looks at how local treatments like surgery, chemotherapy, radiation, hormone therapy, or targeted therapy affect your side effects and quality of life. Researchers want to learn from women with early-stage breast cancer to improve care.
This study looks at how a type of white blood cell in your blood changes while you receive radiation and chemotherapy. The goal is to see whether these blood changes relate to treatment, especially in certain chest (thoracic) cancers.
This study looks at how chemotherapy and immunotherapy affect the body in older adults with colorectal cancer, especially early side effects. It may help researchers understand why some people lose strength and how to better predict and manage treatment toxicity.
This study uses special cells grown in a lab to understand why some cancer treatments cause side effects. It may help researchers find ways to predict and prevent these side effects in the future.
This study looks at how well current methods manage low blood cell counts (low platelets, low white blood cells, and low red blood cells) that can happen from targeted therapies for breast cancer. If you have breast cancer and are getting or have gotten a targeted therapy, this trial could help improve care for side effects like these.
Hear when a new Myelosuppression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.